Stockscreener 앱 받기
142.78
2.17%
-3.17
시간 외 거래:
142.78
전일 마감가:
$145.95
열려 있는:
$145.41
하루 거래량:
630.29K
Relative Volume:
1.35
시가총액:
$4.74B
수익:
$560.03M
순이익/손실:
$-150.66M
주가수익비율:
-29.38
EPS:
-4.86
순현금흐름:
$-87.43M
1주 성능:
-5.74%
1개월 성능:
+1.51%
6개월 성능:
+59.64%
1년 성능:
+44.79%
1일 변동 폭
$141.79
$146.88
1주일 범위
$141.79
$157.13
52주 변동 폭
$55.92
$157.13
Irhythm Technologies Inc Stock (IRTC) Company Profile
명칭
Irhythm Technologies Inc
전화
415-632-5700
주소
699 8TH STREET, San Francisco, CA
IRTC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IRTC
Irhythm Technologies Inc
|
142.78 | 4.74B | 560.03M | -150.66M | -87.43M | -4.86 |
|
ABT
Abbott Laboratories
|
134.11 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.63 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
391.81 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.28 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.02 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Irhythm Technologies Inc Stock (IRTC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-02 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-12-03 | 재개 | Wells Fargo | Equal Weight |
| 2024-10-04 | 개시 | Goldman | Neutral |
| 2024-06-20 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-02-07 | 개시 | Wells Fargo | Overweight |
| 2022-11-07 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2022-06-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-04-06 | 개시 | Wolfe Research | Underperform |
| 2022-02-24 | 업그레이드 | Needham | Hold → Buy |
| 2022-01-18 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-12 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-01-11 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-12-21 | 재개 | Canaccord Genuity | Buy |
| 2021-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-12-15 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-06-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-04-13 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-04-12 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-02-26 | 다운그레이드 | Colliers Securities | Buy → Neutral |
| 2021-01-29 | 재확인 | Needham | Hold |
| 2020-11-17 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-09-11 | 개시 | Needham | Hold |
| 2020-09-02 | 개시 | Robert W. Baird | Neutral |
| 2020-08-07 | 업그레이드 | Colliers Securities | Neutral → Buy |
| 2020-08-05 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-06 | 개시 | BTIG Research | Buy |
| 2020-01-10 | 개시 | William Blair | Outperform |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2019-10-22 | 개시 | Oppenheimer | Perform |
| 2019-02-20 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2018-09-13 | 재확인 | Canaccord Genuity | Buy |
| 2018-09-06 | 개시 | Chardan Capital Markets | Buy |
| 2018-08-02 | 업그레이드 | Dougherty & Company | Sell → Neutral |
| 2018-07-16 | 다운그레이드 | Dougherty & Company | Neutral → Sell |
| 2017-12-01 | 개시 | Dougherty & Company | Neutral |
모두보기
Irhythm Technologies Inc 주식(IRTC)의 최신 뉴스
SHAREHOLDER ALERT: Morris Kandinov Investigating IRTC, - GlobeNewswire
Robbins LLP Informs iRhythm Technologies, Inc. (IRTC) Investors That the Class Action Beat the - Bluefield Daily Telegraph
Robbins LLP Informs iRhythm Technologies, Inc. (IRTC) Investors That the Class Action Beat the Motion to Dismiss - GlobeNewswire
iRhythm at 2025 Truist Securities MedTech Conference: Strategic Growth Plans - Investing.com
Discretionary Denials in Action: iRhythm Technologies Inc. v. Welch Allyn Inc. | ProskauerThe Patent Playbook - JD Supra
File Early or Risk Denial: iRhythm IPR Institution Denial Underscores the Importance of Filing IPR Petitions Sooner Rather Than Later | Regulatory Roundup | Insights - Vinson & Elkins LLP
Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Cardiovascular Digital Solutions Market Generated - openPR.com
GAMMA Investing LLC Acquires 8,660 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC) - Defense World
iRhythm Creates a New Basis for Discretionary Denial - IPWatchdog.com
(IRTC) Investment Report - news.stocktradersdaily.com
Rhumbline Advisers Has $4.81 Million Stake in iRhythm Technologies, Inc. (NASDAQ:IRTC) - Defense World
iRhythm Technologies (NASDAQ:IRTC) shareholders have earned a 57% return over the last year - Yahoo Finance
iRhythm Technologies, Inc. (NASDAQ:IRTC) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
iRhythm: Promising OutlookSo Long As Past Mistakes Are Not Repeated (NASDAQ:IRTC) - Seeking Alpha
iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
iRhythm Technologies (NASDAQ:IRTC) Given New $160.00 Price Target at Morgan Stanley - Defense World
iRhythm Technologies (NASDAQ:IRTC) versus Pulmonx (NASDAQ:LUNG) Head to Head Survey - Defense World
iRhythm Technologies (IRTC) Price Target Raised by Morgan Stanle - GuruFocus
Insider Sell: Chad Patterson Sells Shares of iRhythm Technologies Inc - GuruFocus
IRTC to be Featured in Upcoming BTIG Event in New York | IRTC St - GuruFocus
iRhythm Technologies (IRTC) Price Target Raised by Morgan Stanley | IRTC Stock News - GuruFocus
iRhythm at Goldman Sachs Conference: Strategic Growth and Challenges By Investing.com - Investing.com Canada
Stewart's Newest Discretionary Denial Has Attys On Edge - Law360
iRhythm at Goldman Sachs Conference: Strategic Growth and Challenges - Investing.com
iRhythm (IRTC) Gains Momentum as Morgan Stanley Raises Price Tar - GuruFocus
iRhythm (IRTC) Gains Momentum as Morgan Stanley Raises Price Target | IRTC Stock News - GuruFocus
Morgan Stanley Raises iRhythm Technologies Price Target to $160 From $130, Maintains Overweight Rating - MarketScreener
Cardiac Patch Monitor Market Outlook, Developments, and Strategic Insights by 2031 - openPR.com
Patent Chief Nixes iRhythm Challenges Citing Decade-Old Tech (1) - Bloomberg Law News
Stewart Grants Request to Deny IPR Institution Due to Patent Owner’s ‘Settled Expectations’ - IPWatchdog.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Stockholders to Connect - ACCESS Newswire
iRhythm Technologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Globe and Mail
Patent Office Leader Rejects IPRs Based On 12-Year Wait - Law360
iRhythm Technologies stock hits 52-week high at $147 By Investing.com - Investing.com South Africa
iRhythm Technologies stock hits 52-week high at $147 - Investing.com
Should You Hold iRhythm Technologies (IRTC)? - Insider Monkey
iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
U.S. Smart Wearable ECG Monitors Market Size Report 2030 - Grand View Research
Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks - Yahoo Finance
iRhythm at 45th Annual William Blair Conference: Strategic Growth Insights By Investing.com - Investing.com Canada
Heart Device Maker iRhythm Gets Investor Claims Trimmed - Law360
Global AI in Remote Patient Monitoring Market to Cross USD 13 Billion by 2032 | DelveInsight - GlobeNewswire Inc.
iRhythm Fails to Snuff Investor Suit Over Heart Monitor Flaws - Bloomberg Law News
Healthcare Tech And Innovation: Heart Monitors Improving - Seeking Alpha
iRhythm Technologies Inc (IRTC) Stock Price Up 3.75% on Jun 3 - GuruFocus
Shareholders that lost money on iRhythm Technologies, Inc.(IRTC) should contact Levi & Korsinsky about pending Class ActionIRTC - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Smart Wearable ECG Monitors Market Size Report, 2030 - Grand View Research
INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of iRhythm Technologies, Inc. (IRTC) - ACCESS Newswire
(IRTC) Trading Signals - news.stocktradersdaily.com
Irhythm Technologies Inc (IRTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Irhythm Technologies Inc 주식 (IRTC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Patterson Chad | Chief Commercial Officer |
Jun 23 '25 |
Sale |
150.00 |
936 |
140,400 |
48,929 |
0.54%
1.82%
자본화:
|
볼륨(24시간):